Clinical Trial

Symplicity China Study

Recruiting
View on ClinicalTrials.gov →
Summary
The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-15; most recent amendment 2025-11-13.
Status change: Not Yet Recruiting → Recruiting 2025-11-13
Trial Details
NCT Number NCT07081243
Lead Sponsor Medtronic Vascular
Conditions Resistant Hypertension
Enrollment 500 participants
Start Date 2025-11-11
Primary Completion 2028-06-30 (estimated)
Study Completion 2031-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-17